BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andersen JV, Schousboe A, Verkhratsky A. Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: integration of the glutamate/GABA-glutamine cycle. Prog Neurobiol 2022;:102331. [PMID: 35872221 DOI: 10.1016/j.pneurobio.2022.102331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lohr C. Role of P2Y receptors in astrocyte physiology and pathophysiology. Neuropharmacology 2023;223:109311. [PMID: 36328064 DOI: 10.1016/j.neuropharm.2022.109311] [Reference Citation Analysis]
2 Thapaliya P, Pape N, Rose CR, Ullah G. Modeling the heterogeneity of sodium and calcium homeostasis between cortical and hippocampal astrocytes and its impact on bioenergetics. Front Cell Neurosci 2023;17. [DOI: 10.3389/fncel.2023.1035553] [Reference Citation Analysis]
3 Tang Y, Yan Y, Mao J, Ni J, Qing H. The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease. Ageing Res Rev 2023;:101865. [PMID: 36716975 DOI: 10.1016/j.arr.2023.101865] [Reference Citation Analysis]
4 Li ZH, Jiang YY, Long CY, Peng Q, Yue RS. The gut microbiota-astrocyte axis: Implications for type 2 diabetic cognitive dysfunction. CNS Neurosci Ther 2023. [PMID: 36601656 DOI: 10.1111/cns.14077] [Reference Citation Analysis]
5 Li H, Lai L, Li X, Wang R, Fang X, Xu N, Zhao J. Electroacupuncture Ameliorates Cognitive Impairment by Regulating γ-Amino Butyric Acidergic Interneurons in the Hippocampus of 5 Familial Alzheimer's Disease Mice. Neuromodulation 2023:S1094-7159(22)01398-8. [PMID: 36604241 DOI: 10.1016/j.neurom.2022.11.014] [Reference Citation Analysis]
6 Harrison MA, Morris SL, Rudman GA, Rittenhouse DJ, Monk CH, Sakamuri SS, Jones MJ, Hasan MM, Khatun MS, Wang H, Garfinkel LP, Norton EB, Steele C, Kim S, Kolls JK, Jazwinski SM, Mostany R, Katakam PV, Engler-chiurazzi EB, Zwezdaryk KJ. Intermittent Cytomegalovirus Infection Alters Neurobiological Metabolism and Induces Cognitive Deficits in Mice.. [DOI: 10.1101/2022.12.16.520745] [Reference Citation Analysis]
7 Lapresa R, Agulla J, Bolaños JP, Almeida A. APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer's disease. Front Pharmacol 2022;13:1086540. [PMID: 36588673 DOI: 10.3389/fphar.2022.1086540] [Reference Citation Analysis]
8 Kilb W, Kirischuk S. GABA Release from Astrocytes in Health and Disease. Int J Mol Sci 2022;23. [PMID: 36555501 DOI: 10.3390/ijms232415859] [Reference Citation Analysis]
9 Beltran-lobo P, Reid M, Jimenez-sanchez M, Verkhratsky A, Perez-nievas B, Noble W. Astrocyte adaptation in Alzheimer’s disease: a focus on astrocytic P2X7R. Essays in Biochemistry 2022. [DOI: 10.1042/ebc20220079] [Reference Citation Analysis]
10 Rodríguez-giraldo M, González-reyes RE, Ramírez-guerrero S, Bonilla-trilleras CE, Guardo-maya S, Nava-mesa MO. Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments. IJMS 2022;23:13630. [DOI: 10.3390/ijms232113630] [Reference Citation Analysis]
11 Andersen JV, Schousboe A. Glial Glutamine Homeostasis in Health and Disease. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03771-1] [Reference Citation Analysis]
12 Popov A, Brazhe N, Morozova K, Yashin K, Bychkov M, Nosova O, Sutyagina O, Brazhe A, Parshina E, Li L, Medyanik I, Korzhevskii DE, Shenkarev Z, Lyukmanova E, Verkhratsky A, Semyanov A. Aging impairs astrocytes in the human cerebral cortex.. [DOI: 10.1101/2022.10.31.514523] [Reference Citation Analysis]